1887

Abstract

The genome of hepatitis B virus (HBV) consists of four open reading frames, encoding the envelope proteins (Pre-S/S), the core proteins (Pre-C/C), the polymerase (P) and the transactivating X protein (X). In the sera of HBV-infected patients, hepatitis B surface antigen (HBsAg) particles without the viral genome can outnumber virions by more than 1000-fold. To analyse the interactions between HBsAg and host cells, global gene-expression profiles of a small HBsAg (SHBs)-secreting stable cell line (HepG2-S-G2) and its counterpart control cell line (HepG2-Neo-F4) were compared. Marked upregulation of lymphoid enhancer-binding factor 1 (LEF-1), a transcription factor in the Wnt pathway, was found in SHBs-expressing cells and was confirmed by interference experiments with small interfering RNA. However, compared with the control cells, HepG2-S-G2 did not show higher proliferative competence in culture or increased tumorigenesis in nude mice. A possible mechanism to explain the discrepancy between the upregulation of LEF-1 and the lack of increased tumorigenesis is SHBs expression resulting in altered expression and distribution of LEF-1 protein in cell compartments and upregulation of LEF-1 isoforms that could suppress, rather than enhance, the Wnt pathway.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.83108-0
2007-11-01
2019-12-15
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/11/2966.html?itemId=/content/journal/jgv/10.1099/vir.0.83108-0&mimeType=html&fmt=ahah

References

  1. Alexander, J. J., Bey, E. M., Geddes, E. W. & Lecatsas, G. ( 1976; ). Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 50, 2124–2128.
    [Google Scholar]
  2. Beasley, R. P., Shiao, I. S., Wu, T. C. & Hwang, L. Y. ( 1982; ). Hepatoma in an HBsAg carrier – seven years after perinatal infection. J Pediatr 101, 83–84.[CrossRef]
    [Google Scholar]
  3. Cha, M. Y., Kim, C. M., Park, Y. M. & Ryu, W. S. ( 2004; ). Hepatitis B virus X protein is essential for the activation of Wnt/β-catenin signaling in hepatoma cells. Hepatology 39, 1683–1693.[CrossRef]
    [Google Scholar]
  4. Cheng, J., Imanishi, H., Morisaki, H., Liu, W., Nakamura, H., Morisaki, T. & Hada, T. ( 2005; ). Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFκB pathway in a human monocytic cell line, THP-1. J Hepatol 43, 465–471.[CrossRef]
    [Google Scholar]
  5. Chisari, F. V., Klopchin, K., Moriyama, T., Pasquinelli, C., Dunsford, H. A., Sell, S., Pinkert, C. A., Brinster, R. L. & Palmiter, R. D. ( 1989; ). Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59, 1145–1156.[CrossRef]
    [Google Scholar]
  6. Clayton, R. F., Owsianka, A. & Patel, A. H. ( 2001; ). Evidence for structural differences in the S domain of L in comparison with S protein of hepatitis B virus. J Gen Virol 82, 1533–1541.
    [Google Scholar]
  7. Clevers, H. & van de Wetering, M. ( 1997; ). TCF/LEF factors earn their wings. Trends Genet 13, 485–489.[CrossRef]
    [Google Scholar]
  8. Cordray, P. & Satterwhite, D. J. ( 2005; ). TGF-β induces novel Lef-1 splice variants through a Smad-independent signaling pathway. Dev Dyn 232, 969–978.[CrossRef]
    [Google Scholar]
  9. Coyle-Rink, J., Del Valle, L., Sweet, T., Khalili, K. & Amini, S. ( 2002; ). Developmental expression of Wnt signaling factors in mouse brain. Cancer Biol Ther 1, 640–645.[CrossRef]
    [Google Scholar]
  10. de La Coste, A., Romagnolo, B., Billuart, P., Renard, C. A., Buendia, M. A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C. & other authors ( 1998; ). Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 95, 8847–8851.[CrossRef]
    [Google Scholar]
  11. Ding, Q., Xia, W., Liu, J. C., Yang, J. Y., Lee, D. F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y. & other authors ( 2005; ). Erk associates with and primes GSK-3β for its inactivation resulting in upregulation of β-catenin. Mol Cell 19, 159–170.[CrossRef]
    [Google Scholar]
  12. Eastman, Q. & Grosschedl, R. ( 1999; ). Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 11, 233–240.[CrossRef]
    [Google Scholar]
  13. Ganem, D. & Prince, A. M. ( 2004; ). Hepatitis B virus infection – natural history and clinical consequences. N Engl J Med 350, 1118–1129.[CrossRef]
    [Google Scholar]
  14. Giles, R. H., van Es, L. H. & Clevers, H. ( 2003; ). Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653, 1–24.
    [Google Scholar]
  15. Hildt, E., Munz, B., Saher, G., Reifenberg, K. & Hofschneider, P. H. ( 2002; ). The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J 21, 525–535.[CrossRef]
    [Google Scholar]
  16. Hovanes, K., Li, T. W. & Waterman, M. L. ( 2000; ). The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res 28, 1994–2003.[CrossRef]
    [Google Scholar]
  17. Hovanes, K., Li, T. W., Munguia, J. E., Truong, T., Milovanovic, T., Lawrence Marsh, J., Holcombe, R. F. & Waterman, M. L. ( 2001; ). β-Catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 28, 53–57.
    [Google Scholar]
  18. Kato, T., Satoh, S., Okabe, H., Kitahara, O., Ono, K., Kihara, C., Tanaka, T., Tsunoda, T., Yamaoka, Y. & other authors ( 2001; ). Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis. Neoplasia 3, 4–9.[CrossRef]
    [Google Scholar]
  19. Khan, N., Guarnieri, M., Ahn, S. H., Li, J., Zhou, Y., Bang, G., Kim, K. H., Wands, J. R. & Tong, S. ( 2004; ). Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene. J Virol 78, 3262–3270.[CrossRef]
    [Google Scholar]
  20. Lee, W. M. ( 1997; ). Hepatitis B virus infection. N Engl J Med 337, 1733–1745.[CrossRef]
    [Google Scholar]
  21. Lee, T. K., Man, K., Ho, J. W., Wang, X. H., Poon, R. T., Xu, Y., Ng, K. T., Chu, A. C., Sun, C. K. & other authors ( 2005; ). FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin Cancer Res 11, 8458–8466.[CrossRef]
    [Google Scholar]
  22. Lee, H. C., Kim, M. & Wands, J. R. ( 2006; ). Wnt/Frizzled signaling in hepatocellular carcinoma. Front Biosci 11, 1901–1915.[CrossRef]
    [Google Scholar]
  23. Li, Y., Wasser, S., Lim, S. G. & Tan, T. M. ( 2004; ). Genome-wide expression profiling of RNA interference of hepatitis B virus gene expression and replication. Cell Mol Life Sci 61, 2113–2124.
    [Google Scholar]
  24. Locarnini, S., Shaw, T., Dean, J., Colledge, D., Thompson, A., Li, K., Lemon, S. M., Lau, G. G. & Beard, M. R. ( 2005; ). Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells. J Clin Virol 32, 113–121.[CrossRef]
    [Google Scholar]
  25. Lupberger, J. & Hildt, E. ( 2007; ). Hepatitis B virus-induced oncogenesis. World J Gastroenterol 13, 74–81.[CrossRef]
    [Google Scholar]
  26. Milich, D. R. ( 1997; ). Immune response to the hepatitis B virus: infection, animal models, vaccination. Viral Hepatitis Rev 3, 63–103.
    [Google Scholar]
  27. Nakanishi, F., Ohkawa, K., Ishida, H., Hosui, A., Sato, A., Hiramatsu, N., Ueda, K., Takehara, T., Kasahara, A. & other authors ( 2005; ). Alteration in gene expression profile by full-length hepatitis B virus genome. Intervirology 48, 77–83.[CrossRef]
    [Google Scholar]
  28. Ng, R. K., Lau, C. Y., Lee, S. M., Tsui, S. K., Fung, K. P. & Waye, M. M. ( 2004; ). cDNA microarray analysis of early gene expression profiles associated with hepatitis B virus X protein-mediated hepatocarcinogenesis. Biochem Biophys Res Commun 322, 827–835.[CrossRef]
    [Google Scholar]
  29. Ocama, P., Opio, C. K. & Lee, W. M. ( 2005; ). Hepatitis B virus infection: current status. Am J Med 118, 1413.e15–1413.e22.
    [Google Scholar]
  30. Rehermann, B. & Nascimbeni, M. ( 2005; ). Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5, 215–229.[CrossRef]
    [Google Scholar]
  31. Roberts, L. R. & Gores, G. J. ( 2005; ). Hepatocellular carcinoma: molecular pathways and new therapeutic targets. Semin Liver Dis 25, 212–225.[CrossRef]
    [Google Scholar]
  32. Schmitt-Graeff, A., Ertelt-Heitzmann, V., Allgaier, H. P., Olschewski, M., Nitschke, R., Haxelmans, S., Koelble, K., Behrens, J. & Blum, H. E. ( 2005; ). Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma. Liver Int 25, 839–847.[CrossRef]
    [Google Scholar]
  33. Seeger, C. & Mason, W. S. ( 2000; ). Hepatitis B virus biology. Microbiol Mol Biol Rev 64, 51–68.[CrossRef]
    [Google Scholar]
  34. Sells, M. A., Chen, M. L. & Acs, G. ( 1987; ). Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 84, 1005–1009.[CrossRef]
    [Google Scholar]
  35. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R. & Ben-Ze'ev, A. ( 1999; ). The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96, 5522–5527.[CrossRef]
    [Google Scholar]
  36. Tetsu, O. & McCormick, F. ( 1999; ). β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422–426.[CrossRef]
    [Google Scholar]
  37. Vanlandschoot, P. & Leroux-Roels, G. ( 2003; ). Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?. Trends Immunol 24, 144–147.[CrossRef]
    [Google Scholar]
  38. Wang, X. & Seed, B. ( 2003; ). A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31, e154 [CrossRef]
    [Google Scholar]
  39. Wang, W., Ji, P., Steffen, B., Metzger, R., Schneider, P. M., Halfter, H., Schrader, M., Berdel, W. E., Serve, H. & Muller-Tidow, C. ( 2005; ). Alterations of lymphoid enhancer factor-1 isoform expression in solid tumors and acute leukemias. Acta Biochim Biophys Sin (Shanghai) 37, 173–180.[CrossRef]
    [Google Scholar]
  40. Wen, Y. M., Copeland, J. A., Mann, G. F., Howard, C. R. & Zuckerman, A. J. ( 1981; ). Detection of HBsAg in a clone derived from the PLC/PRF/5 human hepatoma cell line. Arch Virol 68, 157–163.[CrossRef]
    [Google Scholar]
  41. Wu, C. G., Salvay, D. M., Forgues, M., Valerie, K., Farnsworth, J., Markin, R. S. & Wang, X. W. ( 2001; ). Distinctive gene expression profiles associated with hepatitis B virus x protein. Oncogene 20, 3674–3682.[CrossRef]
    [Google Scholar]
  42. Yang, H. I., Lu, S. N., Liaw, Y. F., You, S. L., Sun, C. A., Wang, L. Y., Hsiao, C. K., Chen, P. J., Chen, D. S. & Chen, C. J. ( 2002; ). Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347, 168–174.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.83108-0
Loading
/content/journal/jgv/10.1099/vir.0.83108-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error